Search - tctmd.com

Displaying 21 - 40 of 184

Sort: Relevancy | Date

September 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

September 01, 2024

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 19, 2024

August 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

August 01, 2024

Leaks After LAAO Do Matter, Experts Agree

News Conference News NY Valves 2024

Leaks After LAAO Do Matter, Experts Agree

June 10, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Potential Contributors to ESUS Explored in New Consensus Statement

News Daily News

Potential Contributors to ESUS Explored in New Consensus Statement

May 14, 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

News Conference News EHRA 2024

Stroke Rates Fall Among AF Patients Not on Anticoagulation

April 11, 2024

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

March 15, 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

News Conference News ISC 2024

Speedier Anticoagulation Reversal Tied to Better ICH Outcomes

February 15, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

February 13, 2024

Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains

News Conference News ISC 2024

Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains

February 12, 2024

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

September 18, 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

News Conference News ESOC 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

May 26, 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

News Conference News ESOC 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

May 25, 2023

Does All AF After Stroke Warrant Anticoagulation? Experts Debate

News Conference News ISC 2023

Does All AF After Stroke Warrant Anticoagulation? Experts Debate

February 17, 2023

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

News Daily News

Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke

December 21, 2022

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.